Dialysis News and Research

Latest Dialysis News and Research

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced new preclinical data on the efficacy of anti-galectin therapy on diabetic kidney disease.

23 Jan 2013

DaVita forms joint venture with Riches Healthcare

DaVita, the kidney care division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced the formation of a joint venture with Riches Healthcare (RHC), through which a new entity - DaVita Taiwan - will provide services to four dialysis clinics. DaVita will own a majority share of the joint venture entity.

21 Jan 2013

Income disparities, segregation may account for survival differences in U.S. hemodialysis patients

Complex socioeconomic and residential factors may account for differences in survival between Black and White kidney failure patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

19 Jan 2013

Atrial fibrillation increases risk of kidney failure in people with CKD

Many people who suffer from chronic kidney disease progressively lose their kidney function over time and eventually develop a condition called end-stage renal disease - the complete failure of the kidneys - placing them in need of lifelong dialysis or a kidney transplant.

18 Jan 2013

True extent of life-support buy-in revealed

Many surgeons contract informally with patients preoperatively about the use of postoperative life support, report researchers.

17 Jan 2013

Argon Medical to launch Cleaner15 technology for mechanical thrombectomy procedures

Furthering its commitment to advancing the treatment of patients diagnosed with ESRD (End Stage Renal Disease), Argon Medical Devices, Inc. takes another leap forward with the launch of the Cleaner15 Rotational Thrombectomy System.

17 Jan 2013

Top-line results from Amgen’s Aranesp Phase 3 trial on heart failure and anemia

Amgen today announced top-line results of the Phase 3 Aranesp (darbepoetin alfa) RED-HF (Reduction of Events With Darbepoetin Alfa in Heart Failure) Trial.

17 Jan 2013

SLU researchers examine health outcomes for obese transplant recipients

In a research review article published in the American Journal of Nephrology, Saint Louis University investigators examined data from multiple studies to better understand how obesity, an epidemic in the U.S., impacts kidney transplant patients.

16 Jan 2013

Obesity complicates kidney transplantation

The risk for delayed graft function in patients undergoing kidney transplant rises in line with their body mass index, say US researchers.

14 Jan 2013

Toxin-induced insulin resistance combated in mice

French researchers have found that a protein-bound uremic toxin, p-cresyl sulfate, contributes to the development of insulin resistance in mice, providing a new potential therapeutic target for treating chronic kidney disease, they say.

4 Jan 2013

Congressional accord preserves Medicare doctor pay

The deal averts for one year a 26.5 percent cut in payments to doctors who treat Medicare patients. It also repeals the long-term care provision of the 2010 health overhaul.

3 Jan 2013

US acute kidney injury deaths ‘double in past decade’

A US study has found that the most severe form of acute kidney injury has increased nationwide by an average 10% per year with the number of associated deaths doubling over the past decade.

28 Dec 2012

Targeting PCS may help improve health of patients with chronic kidney disease

Insulin resistance, or prediabetes, in individuals with kidney disease may be caused by the progressive retention of certain compounds that are normally excreted by the kidneys in healthy individuals, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

21 Dec 2012

NCKU's wireless monitoring system helps track physiological status of dialysis patients

A wireless physiological monitoring system designed by the Department of Biomedical Engineering (BME) of National Cheng Kung University (NCKU), southern Taiwan, has proved to increase medical efficiency and safety for dialysis patients.

18 Dec 2012

Three critical illness factors independently associated with increased risk of dementia

Older people often worry about dementia and while some risks are known, for example alcoholism or stroke, the effects of illness are less clear. New research published in BioMed Central's open access journal Critical Care looks at illness requiring hospitalization and treatment in the intensive care unit (ICU) and finds that infection or severe sepsis, neurological dysfunction, such as delirium, or acute dialysis are all independently associated with an increased risk of a subsequent diagnosis of dementia.

17 Dec 2012

Study tracks movements of leukocytes through the kidney

Better targeted treatments for 20 per cent of renal failure patients are on the horizon following a key discovery about the role of white blood cells in kidney inflammation.

16 Dec 2012

BioScrip to acquire HomeChoice

BioScrip, Inc. today announced that it has entered into a definitive agreement to acquire HomeChoice Partners, Inc., a leading provider of alternate-site infusion pharmacy services, for $70.0 million in cash.

13 Dec 2012

Astellas, FibroGen commence FG-4592/ASP1517 Phase 3 clinical program in CKD anemia

FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.

12 Dec 2012

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene International Sàrl today announced that results from a study evaluating the combination of REVLIMID (lenalidomide) plus VIDAZA (azacitidine) in patients 60 years or older with untreated acute myeloid leukemia (AML) were presented at the American Society of Hematology annual meeting in Atlanta, GA.

11 Dec 2012

Study reveals increase in incidence of dialysis-requiring acute kidney injury

Acute kidney injury (AKI), an abrupt or rapid decline in kidney function, is a serious and increasingly prevalent condition that can occur after major infections, major surgery, or exposure to certain medications.

7 Dec 2012